Atrial Fibrillation Detected After Stroke and Increased Risk of Death
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published February 10, 2021.
Article Versions
- Previous version (February 10, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Luciano A. Sposato, MD, MBA, FRCPC and
- David J. Seiffge, MD
- Luciano A. Sposato, MD, MBA, FRCPC and
Bayer Canada
NONE
(1) Boehringer Ingelheim (speaker honoraria), Pfizer, Kathleen & Dr Henry Barnett (2) Barnett Chair in Stroke Research (Western University, London, Ontario, Canada) (3) Edward and Alma Saraydar Neurosciences Fund (London Health Sciences Foundation) (4) Opportunities Fund of the Academic Health Sciences Center Alternative Funding Plan of the Academic Medical Organization of Southwestern Ontario (AMOSO) (4) Bayer Pharmaceuticals (5) Pfizer INC. (6) Gore
Editorial board: Neurology and Stroke Journal. Leadership group: World Stroke Academy. Chair: Brain and Heart, World Stroke Organization
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David J. Seiffge, MD
Advisory board: Bayer, Pfizer, Portola/Alexion
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Compensations from STAGO for educational efforts
NONE
Bayer Foundation ("Thrombosis research Award 2017")
NONE
NONE
Swiss Heart Foundation, Bangerter and Rhyner Foundation, Swiss Society of Neurology, Swiss National Science Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Clinical Neurological Sciences, Anatomy and Cell Biology, and Epidemiology and Biostatistics (L.A.S.), Schulich School of Medicine and Dentistry, Heart & Brain Laboratory (L.A.S.), and Robarts Research Institute (L.A.S.), Western University; Lawson Research Institute (L.A.S.), London, Ontario, Canada; and Department of Neurology and Stroke Center (D.J.S.), University Hospital Inselspital, Bern, Switzerland.
- Correspondence
Dr. Sposato Luciano.Sposato{at}Lhsc.on.ca
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.